Infection by Plasmodium falciparum parasites can lead to substantial protective immunity to
malaria, and available evidence suggest that acquisition of protection against some severe
malaria syndromes can be fairly rapid. Although these facts have raised hopes that the
development of effective vaccines against this major cause of human misery is a realistic
goal, the uncertainty regarding the antigenic targets of naturally acquired protective
immunity and the immunological mechanisms involved remain major vaccine development …